Apalutamide
Who holds supplier records for Apalutamide? 14 organisations hold a current record for Apalutamide: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (8) and China (5); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Apalutamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/apalutamide
Reading the evidence
- 14 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
8 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 10 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Apalutamide expires 15 Feb 2044. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (14)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Apalutamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BEIJING HOPE PHARMACEUTICAL CO LTDActive DMF 40362, 44872 · latest filing Sept 2026
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 35740, 34667 · latest filing Mar 2021
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 40927, 36394 · latest filing Dec 2024
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 41700, 34711 · latest filing Mar 2025
- AARTI PHARMALABS LIMITEDIndiaActive DMF 43909 · latest filing Apr 2026
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 36028 · latest filing Sept 2021
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 36254 · latest filing Sept 2021
- Aurisco Pharmaceutical Co.,ltdChina Company GMP cert on recordActive DMF 39890 · latest filing May 2024
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChina Company GMP cert on recordActive DMF 41062 · latest filing Jan 2025
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 36165 · latest filing Sept 2021
- Sichuan Kelun Pharmaceutical Co., Ltd.ChinaActive DMF 42030 · latest filing May 2025
- Zhejiang Hisun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 43286 · latest filing Dec 2025
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.ChinaActive DMF 43562 · latest filing Apr 2026
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 36264 · latest filing Sept 2021
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Apalutamide are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- China · Inactive DMF 39029 · filed Nov 2023
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (3 listed products contain Apalutamide). The latest listed patent expires 15 Feb 2044. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Apalutamide is a nonsteroidal antiandrogen used in the treatment of prostate cancer. It works by inhibiting the action of androgens (male hormones) that can promote tumor growth.
Chemical identity
- IUPAC name
- 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide
- Canonical SMILES
- CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F
- InChIKey
- HJBWBFZLDZWPHF-UHFFFAOYSA-N
- Synonyms
- Erleada API, arn-509, erleada, jnj-56021927
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Apalutamide?
14 organisations hold an active US FDA Type II Drug Master File or a CEP for Apalutamide: BEIJING HOPE PHARMACEUTICAL CO LTD, Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), MSN Laboratories Private Limited (India), AARTI PHARMALABS LIMITED (India), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India) and Aurisco Pharmaceutical Co.,ltd (China), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Apalutamide Drug Master Files are active?
BEIJING HOPE PHARMACEUTICAL CO LTD (DMF 40362, 44872), Dr. Reddy's Laboratories Ltd. (DMF 35740, 34667), Hetero Labs Limited (DMF 40927, 36394), MSN Laboratories Private Limited (DMF 41700, 34711), AARTI PHARMALABS LIMITED (DMF 43909), Alembic Pharmaceuticals Limited (DMF 36028), APITORIA PHARMA PRIVATE LTD (DMF 36254) and Aurisco Pharmaceutical Co.,ltd (DMF 39890) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Apalutamide records mean?
1 organisation has only inactive Type II DMFs for Apalutamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Apalutamide?
Yes. The latest patent listed for an approved US product containing Apalutamide expires 15 Feb 2044, across 3 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Apalutamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Apalutamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.